A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators-Reference-Cited by-同舟云学术

A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators

Published:2016-05-25 Issue: Volume:7 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Brenner Annette K.,Reikvam Håkon,Bruserud Øystein

Funder

Helse Vest

Kreftforeningen

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

2. Update on rational targeted therapy in AML;Shafer;Blood Rev,2016

3. Emerging therapeutic drugs for AML;Stein;Blood,2016

4. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells;Bruserud;Haematologica,2007

5. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts;Bruserud;Haematologica,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity;Journal of Clinical Medicine;2023-08-25

2. Whole transcriptome sequencing reveals HOXD11-AGAP3, a novel fusion transcript in the Indian acute leukemia cohort;Frontiers in Genetics;2023-04-11

3. Does the Chemotherapy Protocol Affect CXCL12/CXCR4 Axes in Acute Myeloid Leukemia Patients with Monocytic Differentiation?;MIDDLE EAST J CANCER;2022

4. Effect of Chemotherapy on Serum Level of CCL2 in Acute Myeloid Leukemia Patients with Monocytic Differentiation;Medical Laboratory Journal;2021-07-01

5. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment;Frontiers in Immunology;2021-06-17